References
- Abramowicz, M. (2000). Treatment of Lyme disease. Med. Letter, 42, 37-39.
- Anonymous (2008). Reported Cases of Lyme Disease by Year, 2007, United States, 1991-2006. September 27, 2007 (cited 2008 March 26); Available at: http://www.cdc.gov/ncidod/dvbid/lyme/ld_UpClimbLymeDis.htm.
- Anonymous (2012). Categorical data analysis using the SAS system.
- Anonymous (2014). Statistical data on incidence of infectious diseases in Latvia 2014. Available at: http://www.ecdc.europa.eu/en/publications/publications/tbe-in-euefta. pdf (accessed 03.06.2016).
- Auwaerter, P. G., Aucott, J., Dumler, J. S. (2004). Lyme borreliosis (Lyme disease): Molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment. Expert Rev. Mol. Med., 6 (2), 1-22.
- Auwaerter, P. G. (2007). Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to Lyme disease. Clin. Infect. Dis., 45 (2), 143-148.
- Bateman, H., Sigal, L. (2000). Update on Lyme Carditis. Curr. Infect. Dis. Rep., 2 (4), 299-301.
- Bunikis, J., Barbour, A. G. (2002). Laboratory testing for suspected Lyme disease. Med. Clin. North Amer., 86 (2), 311-340.
- Fallon, B. A., Keilp, J. G., Corbera, K. M., Petkova, E., Britton, C. B., Dwyer, E., Slavov, I., Cheng, J., Dobkin, J., Nelson, D. R., Sackeim, H. A. (2008). A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology, 70 (13), 992-1003.
- Feder, H. M. Jr, Johnson, B. J. B., O’Connell, S., Shapiro, E. D., Steere, A. C., Wormser, G. P. (2007). The Ad Hoc International Lyme Disease Group. A critical appraisal of Chronic Lyme Disease. New Engl. J. Med., 357, 1422-1430.
- Fleming, R. V., Marques, A. R., Klempner, M. S., Schmid, C. H., Dally, L. G., Martin, D. S., Philipp, M. T. (2004). Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis., 23 (8), 615-618.
- Halperin, J. J. (2003). Lyme disease and the peripheral nervous system. Muscle Nerve, 28 (2), 133-143.
- Halperin, J. J. (2005). Central nervous system Lyme disease. Curr. Neurol. Neurosci. Rep., 5 (6), 446-452.
- Halperin, J. J, Shapiro, E. D., Logigian, E., Belman, A. L., Dotevall, L., Wormser, G. P., Krupp, L., Gronseth, G., Bever, C. T. Jr. (2007). Practice parameter: Treatment of nervous system Lyme disease (An evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 69, 91-102.
- Hu, L. (2005). Lyme arthritis. Infect. Dis. Clin. North Amer., 19 (4), 947-961.
- Klitz, W., Maiers, M., Spellman, S., Baxter-Lowe, L. A., Schmeckpeper, B., Williams, T. M., Fernandez-Vina, M. (2003). New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens. 62, 296-307.
- Kotsch, K., Wehling, J., Blasczyk, R. (1999). Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: Sequencing based typing of HLA-DRB genes. Tissue Antigens, 53, 486-497.
- Mullegger, R. R. (2004). Dermatological manifestations of Lyme borreliosis. Eur. J. Dermatol., 14, 296-309.
- Nadelman, R. B., Nowakowski, J., Fish, D., Falco, R. C., Freeman, K., McKenna, D., Welch, P., Marcus, R., Aguero-Rosenfeld, M. E., Dennis, D. T., Wormser, G. P. (2001). Tick Bite Study Group. Prophylaxis with single- dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. New Engl. J. Med., 345, 79-84.
- Nowakowski, J., Nadelman, R. B., Sell, R., McKenna, D., Cavaliere, L. F., Holmgren, D., Gaidici, A., Wormser, G. P. (2003). Long-term follow- up of patients with culture-confirmed Lyme disease. Amer. J. Med., 115, 91-96.
- Olerup, O., Aldener, A., Fogdell, A. (1993). HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP). Tissue Antigens, 41 (3), 119-134.
- Oksi, J., Nikoskelainen, J., Hiekkanen, H., Lauhio, A., Peltomaa, M., Pitkäranta, A., Nyman, D., Granlund, H., Carlsson, S. A., Seppälä, I., Valtonen, V., Viljanen, M. (2007). Duration of antibiotic treatment in disseminated Lyme borreliosis: A double-blind, randomized, placebo-controlled, multicenter clinical study. Eur. J. Clin. Microbiol. Infect. Dis., 26, 571-581.
- Philipp, M. T., Wormser, G. P., Marques, A. R., Bittker, S., Martin, D. S., Nowakowski, J.,. Dally, L. G. (2005). A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin. Diagn. Lab. Immunol., 12 (9), 1069-1074.
- Piacentino, J..D., Schwartz, B. S. (2002). Occupational risk of Lyme disease: An epidemiological review. Occup. Environ. Med., 59 (2), 75-84.
- Qureshi, M. Z., New, D., Zulqarni, N. J., Nachman, S. (2002). Overdiagnosis and overtreatment of Lyme disease in children. Pediatr. Infect. Dis. J., 21, 12-14.
- Schoen, R. T., Sikand, V. K., Caldwell, M. C., Van Hoecke, C., Gillet, M., Buscarino, C., Parenti, D. L. (2000). Safety and immunogenicity profile of a recombinant outer surface protein A Lyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months. Clin. Therapeutics, 22, 315-325.
- Seltzer, E. G., Gerber, M. A., Cartter, M. L., Freudigman, K., Shapiro, E. D. (2000). Long-term outcomes of persons with Lyme disease. The Journal of the American Medical Association (JAMA), 283, 609-616.
- Sikand, V. K., Halsey, N., Krause, P. J., Sood, S. K., Geller, R., Van Hoecke, C., Buscarino, C., Parenti, D. (2001). Pediatric Lyme Vaccine Study Group. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in healthy children and adolescents:Arandomized controlled trial. Pediatrics, 108, 123-128.
- Smith, R. P., Schoen, R. T., Rahn, D. W., Sikand, V. K., Nowakowski, J., Parenti, D. L., Holman, M. S., Persing, D. H., Steere, A. C. (2002). Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann. Intern. Med., 136, 421-428.
- Steere, A. C. (2001). Lyme disease. New Engl. J. Med., 345, 115-125.
- Steere, A. C., Gross, D, Meyer, A. L., Huber, B. T. (2001). Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J. Autoimmun., 16, 263-268.
- Steere A. C., Dhar. A, Hernandez, J., Fischer, P. A., Sikand, V. K., Schoen, R. T., Nowakowski, J., McHugh, G., Persing, D. H. (2003). Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Amer. J. Med., 114, 58-62.
- Steere, A. C., Falk, B., Drouin, E. E., Baxter-Lowe, L. A., Hammer, J., Nepom, G. T. (2003). Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum., 48, 534-540.
- Steere, A. C., McHugh, G., Suarez, C., Hoitt, J., Damle, N., Sikand, V. K. (2000). Prospective study of coinfection in patients with erythema migrans. Clin. Infect. Dis., 36, 1078-1081.
- Steere, A. C., Klitz ,W., Drouin, E. E., Falk, B. A., Kwok, W. W., Nepom, G. T. Baxter-Lowe, L. A. (2006). Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J. Exp. Med., 203, 961-971.
- Stricker, R. B. (2007). Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin. Infect. Dis., 45, 149-157.
- Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J. S., Nadelman, R. B. (2006). The clinical assessment, treatment and prevention of Lyme disease, human granulocytic Anaplasmosis, and Babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis., 43, 1089-1134.
- Wormser, G. P., Nadelman, R. B., Dattwyler, R. J., Dennis, D. T., Shapiro, E. D., Steere, A. C., Rush, T. J., Rahn, D. W., Coyle, P. K., Persing, D. H., Fish, D., Luft, B. J. (2000). Infectious Diseases Society of America Practice Guidelines for the Treatment of Lyme Disease. Clin. Infect. Dis., 31 (Suppl 1), S1-S14. (also available at: www.idsociety.org).
- Wormser, G. P., Ramanathan, R., Nowakowski, J., McKenna, D., Holmgren, D., Visintainer, P., Dornbush, R., Singh, B., Nadelman, R. B. (2003). Duration of antibiotic therapy for early Lyme disease: A randomized, double- blind, placebo-controlled trial. Ann. Intern. Med., 138, 697-704.